Cargando…
High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas
Oncocytic L-type amino acid transporter (LAT) 1 may be a prognostic indicator and target of new molecular therapeutic agents against malignancies. To investigate whether LAT1 expression influence the outcomes of patients with bile duct cancer, the expression of LAT1, LAT2, CD98, and Ki-67 was invest...
Autores principales: | Yanagisawa, Nobuyuki, Hana, Kiyomi, Nakada, Norihiro, Ichinoe, Masaaki, Koizumi, Wasaburo, Endou, Hitoshi, Okayasu, Isao, Murakumo, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302674/ https://www.ncbi.nlm.nih.gov/pubmed/24890221 http://dx.doi.org/10.1002/cam4.272 |
Ejemplares similares
-
Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer
por: Ichinoe, Masaaki, et al.
Publicado: (2021) -
REV7 in Cancer Biology and Management
por: Murakumo, Yoshiki, et al.
Publicado: (2023) -
Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity
por: Schmuck, Rosa B., et al.
Publicado: (2015) -
S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma
por: Katono, Ken, et al.
Publicado: (2017) -
Papillary Adenocarcinoma of the Common Bile Duct
por: Arioğul, O., et al.
Publicado: (1995)